• Media Centre
  • Investor relations
  • Client area
  • Client area
  • Stewardship policy
  • Annual reports service

Form of Proxy

INDIVIOR PHARMACEUTICALS, INC.

Notes

No. Proposition For Against Abstain
1

Election of Director: Dr. David Wheadon

2

Election of Director: Joe Ciaffoni

3

Election of Director: Dr. Keith Humphreys

4

Election of Director: Tony Kingsley

5

Election of Director: Daniel Ninivaggi

6

Election of Director: Barbara Ryan

7

Election of Director: Mark Stejbach

8

Election of Director: Juliet Thompson

9

To approve, on an advisory basis, the compensation of our named executive officers.

10

To indicate, on an advisory basis, the preferred frequency of shareholder advisory votes on the compensation of our named executive officers.

11

To ratify the appointment of PricewaterhouseCoopers LLP (US) as our independent registered public accounting firm for the fiscal year ending December 31, 2026.